Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis

Clinical and Experimental Immunology

Volumn 112, Issue 3, 1998, Pages 507-515

  Orth, T ^a   Kellner, R ^a   Diekmann, O ^b   Faust, J ^a   Meyer Zum Buschenfelde K H ^a   Mayet, W J ^a,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c I Department of Internal Medicine   (Germany)

Author keywords

enolase; ANCA; Autoantibody; Catalase; Primary sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; AUTOANTIBODY; CATALASE; ENOLASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GALLBLADDER EPITHELIUM; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; OXIDATIVE STRESS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AUTOANTIBODIES; AUTOIMMUNITY; BLOTTING, WESTERN; CATALASE; CHOLANGITIS, SCLEROSING; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOPYRUVATE HYDRATASE;

EID: 0031861647     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00583.x     Document Type: Article

References (38)

1. Wiessner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 1994; 69:969-82.
2. Boberg KM, Lundin KEA, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol 1994; 29 (Suppl 20): 47-58.
3. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Schuer PJ, Sherlock S. Primary sclerosing cholangitis - A review of its clinical features, cholangiography and hepatic histology. GUT 1990; 21:870-7.
4. Gur H, Shen G, Sutjita M et al. Autoantihody profile of primary sclerosing cholangitis. Pathobiology 1995; 63:76-82.
5. Nielsen H, Wiik A, Elmgreen J. Granulocyte specific antibodies in ulcerative colitis. APMIS 1983; 91:23-26.
6. Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989; 76:30-33.
7. Saxon A, Shanahan F, Lander C, Ganz T, Targan SR. A subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86:202-10.
8. Rump JA, Schölmerich J, Gross V et al. A new type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990; 181:406-13.
9. Duerr RH, Targan SR, Landers CJ, Larusso NF, Lindsay K, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100:1385-91.
10. Klein R, Weisenburg J, Weber P, Seibold F, Berg PA. Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 1991; 14:1147-52.
11. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of autoantibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33:657-62.
12. Lo SK, Fleming KA, Chapman RW. Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992; 33:1370-5.
13. Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992; 33:668-74.
14. Halbwachs-Mecarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, Grünfeld JD, Lesavre P. Antineutrophil cytoplastic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992; 90:79-84.
15. Hardarson S, LaBrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutorphil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Am J Clin Pathol 1993; 99:277-81.
16. Pool MO, Ellerbroek PM, Ridwan BU et al. Serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut 1993; 34:46-50.
17. Peen E, Almer S, Bodemar G, Ryden BO, Sjölin C, Tejle K, Skogh T. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993; 34:56-62.
18. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic autoantibodies in autoimmune liver disease. Hepatology 1993; 17:411-7.
19. Ellerbroek PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BME, Kr von dem Bome AEG, Meuwissen SGM, Goldschmeding R. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 1994; 47:257-62.
20. Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: Characterization and clinical correlates. Clin Exp Immunol 1994; 95:490-7.
21. Orth T, Gerken G, Meyer zum Büschenfelde KH, Mayet WJ. Antineutrophil nuclear antibodies (ANNA) in patients with primary biliary cirrhosis: their prevalence and antigen specificity. Z Gastroenterol 1997; 35:113-21.
22. Lo SK, Fleming KA. Investigation of the specific autoantigen of primary sclerosing cholangitis by Western blotting and immunoprecipitation. Hepatology 1993; 18:469-71 (letter).
23. Tschesche H. Human neutrophil collagenase. Methods Enzymol 1995; 248:431-49.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye bending. Anal Biochem 1976; 72:248-54.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature 1970; 227:680-5.
26. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
27. Kellner R, Orth T, Mayet WJ. Characterization of target antigens from anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis type-1. Electrophoresis 1997; 18:507-10.
28. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10.
29. Auth MKH, Keitzer R, Scholz M, Blaheta RA, Hottenrott EC, Herrmann G, Encke A, Markus BH. Establishment and immunological characterization of cultured human gallbladder epithelial cells. Hepatology 1993; 18:546-55.
30. Van den Munckhof RJ. In situ heterogeneity of peroxisomal oxidase activities: an update. Histochem J 1996; 28:401-29.
31. Ballinger CA, Mendis-Handagama SMLC, Kalmar JR, Arnold RR, Kinkade JM. Changes in the localization of catalase during differentiation of netrophilic granulocytes. Blood 1994; 83:2654-68.
32. Michiels C, Raes M, Tossaint O, Rmacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 1994; 17:235-48.
33. Moodie FDL, Leaker B, Cambrifge G, Totty NF, Segal AW. Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney In 1993; 43:675-81.
34. Akisawa N, Maeda T, Iwasaki S, Onishi S. Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. J Hepatol 1997; 26:845-51.
35. Sherlock S. Pathogenesis of sclerosing cholagnitis: the role of nonimmune factors. Semin Liver Dis 1991; 11:5-10.
36. Mayet WJ, Csemok E, Szymkowiak C, Gross WL, Meyer zum Büschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82:1221-9.
37. Mayet WJ, Meyer zum Büschenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993; 94:440-6.
38. Ludwig J, Batts KP, MacCarthy RL. Ischemic cholangitis in hepatic allografts. Mayo Clin Proc 1992; 67:519-26.